BAX Stock: Price, Earnings History and SEC Filings
Baxter International Inc. (BAX) last traded at $23.00, down 2.13% on the latest session and down 4.2% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $0.58 against an analyst estimate of $0.51, a beat of 13.7%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
BAX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 29, 2026 | $0.58 | $0.51 | +13.73% |
| Jun 2026 | Jul 30, 2026 | $0.56 | $0.36 | +55.56% |
| Mar 2026 | Apr 30, 2026 | $0.36 | $0.31 | +16.13% |
| Dec 2025 | Feb 12, 2026 | $0.44 | $0.53 | -16.98% |
BAX beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How BAX reacts to earnings
Across its last 8 earnings releases, BAX moved 10.3% on average the next session, in either direction. It rose after 3 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-29 | Before open | -7.70% |
| 2026-07-30 | Before open | +7.99% |
| 2026-04-30 | Before open | +4.02% |
| 2026-02-12 | Before open | -15.99% |
| 2025-10-30 | Before open | -14.54% |
| 2025-07-31 | Before open | -22.42% |
| 2025-05-01 | Before open | -1.60% |
| 2025-02-20 | Before open | +8.50% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
BAX financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $11.2B | -$957M | – | -8.5% | $-1.87 |
| 2024 | $10.6B | -$649M | – | -6.1% | $-1.27 |
| 2023 | $10.4B | $2.7B | – | 25.6% | $5.23 |
| 2022 | $10.1B | -$2.4B | – | -24.2% | $-4.83 |
| 2021 | $12.1B | $1.3B | – | 10.6% | $2.53 |
| 2020 | $11.7B | $1.1B | – | 9.4% | $2.13 |
| 2019 | $11.4B | $1.0B | – | 8.8% | $1.93 |
| 2018 | $11.1B | $1.5B | – | 13.9% | $2.83 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for BAX
- 10-Q · Oct 29, 2026
- 8-K · Oct 29, 2026Results of operations, Other events, Financial statements and exhibits
- 8-K · Aug 19, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 18, 2026Material agreement, Other events, Financial statements and exhibits
- 8-K · Aug 4, 2026Officer or director change
- 8-K · Aug 4, 2026Other events, Financial statements and exhibits
- 10-Q · Jul 30, 2026
- 8-K · Jul 30, 2026Results of operations, Other events, Financial statements and exhibits
- 8-K · Jul 14, 2026Regulation FD disclosure, Financial statements and exhibits
- 8-K · May 8, 2026Officer or director change, Bylaw change, Shareholder vote
Insider filing activity
BAX insiders filed 3 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
BAX news
- BAX Q3 deep dive: cost actions and product changes shape outlook amid market cautionOct 30, 2026 · finance.yahoo.com
- Baxter International Inc. Q3 2026 Earnings Call SummaryOct 30, 2026 · app.moby.co
- Baxter’s shares fall as Q3 probability dips despite revenue growthOct 30, 2026 · medicaldevice-network.com
- What Baxter International (BAX) Said on Its Q3 Earnings CallOct 30, 2026 · marketbeat.com
- Baxter International (BAX) Received An FDA Warning Letter Over CGMP ViolationsOct 30, 2026 · finance.yahoo.com
- Baxter (BAX) Q3 2026 Earnings Call TranscriptOct 29, 2026 · fool.com
- Baxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook RaisedOct 29, 2026 · finance.yahoo.com
- What Sent GE HealthCare Stock Higher?Oct 29, 2026 · trefis.com
About Baxter International Inc.
Baxter International Inc. (BAX) is a US-listed public company on NYSE. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in DE. Its fiscal year ends in December.